Comparison of prostate volume measured by transrectal ultrasound and magnetic resonance imaging: Is transrectal ultrasound suitable to determine which patients should undergo active surveillance?

被引:21
作者
Weiss, Brian E. [1 ]
Wein, Alan J. [1 ]
Malkowicz, S. Bruce [1 ]
Guzzo, Thomas J. [1 ]
机构
[1] Univ Penn, Div Urol, Perelman Sch Med, Philadelphia, PA 19104 USA
关键词
Active surveillance; Prostate volume; PSA density; MRI; Transrectal ultrasound; ENDORECTAL SURFACE COIL; RADICAL PROSTATECTOMY; ULTRASONOGRAPHY; CANCER; ACCURACY;
D O I
10.1016/j.urolonc.2012.03.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: To compare prostate volume obtained by transrectal ultrasound (TRUS) and endorectal MRI (eMRI) to assess the reliability of TRUS in determining prostate-specific antigen (PSA) density. Materials and methods: Data for 2,410 patients diagnosed with localized prostate cancer (CaP) and treated with radical retropubic prostatectomy (RRP) at the University of Pennsylvania Health System between 1991 and 2005 was reviewed. Of these patients, 756 had both a preoperative TRUS and eMRI of the prostate performed. Prostate size was estimated using the prolate ellipsoid formula (height X width X length x pi/6); maximal height or antero-posterior (A-P) diameter was determined using a midsagittal view for TRUS and an axial view for eMRI. Pearson's correlation, linear regression, and paired t-test were performed to compare prostate volumes estimated via both imaging modalities. Results: Average prostate size measured with TRUS and eMRI correlated significantly with one another (R = 0.801; P < 0.0001), demonstrating a strong linear relationship (y = 0.891x + 2.622, R-2 = 0.642). Comparison of PSA density also demonstrated a strong linear relationship (y = 0.811x + 0.053, R-2 = 0.765). Average prostate volume differed by 1.7 ml (TRUS relative to eMRI), which was statistically significant based on a paired t-test (P < 0.001). Upon stratification of patients into three groups based on average TRUS volume (<= 30, >30-60, and >60 ml), significant correlation (0.318, 0.564, 0.650) and difference between volumes (-2.1, 4.0, 5.1 ml; P < 0.0001, P < 0.0001, P < 0.05 TRUS relative to eMRI) was maintained. Conclusions: Prostate volume estimations with TRUS and eMRI are highly correlated. It is therefore, reasonable to conclude that in the hands of an experienced sonographer, TRUS is not only an efficient and economical examination, but also an accurate and reproducible modality to estimate prostate size. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:1436 / 1440
页数:5
相关论文
共 50 条
  • [21] Are Magnetic Resonance Imaging-Transrectal Ultrasound Guided Targeted Biopsies Noninferior to Transrectal Ultrasound Guided Systematic Biopsies for the Detection of Prostate Cancer?
    Delongchamps, Nicolas Barry
    Portalez, Daniel
    Bruguiere, Eric
    Rouviere, Olivier
    Malavaud, Bernard
    Mozer, Pierre
    Fiard, Gaelle
    Cornud, Francois
    JOURNAL OF UROLOGY, 2016, 196 (04) : 1069 - 1075
  • [22] How Often Does Magnetic Resonance Imaging Detect Prostate Cancer Missed by Transrectal Ultrasound?
    Herlemann, Annika
    Overland, Maya R.
    Washington, Samuel L.
    Cowan, Janet E.
    Westphalen, Antonio C.
    Carroll, Peter R.
    Nguyen, Hao G.
    Shinohara, Katsuto
    Cooperberg, Matthew R.
    EUROPEAN UROLOGY FOCUS, 2021, 7 (06): : 1268 - 1273
  • [23] Should Hypoechoic Lesions on Transrectal Ultrasound Be Sampled During Magnetic Resonance Imaging-targeted Prostate Biopsy?
    Shakir, Nabeel A.
    Siddiqui, M. Minhaj
    George, Arvin K.
    Kongnyuy, Michael
    Ho, Richard
    Fascelli, Michele
    Merino, Maria J.
    Turkbey, Baris
    Choyke, Peter L.
    Wood, Bradford J.
    Pinto, Peter A.
    UROLOGY, 2017, 105 : 113 - 117
  • [24] Clinically low-risk prostate cancer: evaluation with transrectal doppler ultrasound and functional magnetic resonance imaging
    Novis, Maria Ines
    Baroni, Ronaldo Hueb
    de Oliveira Cerri, Luciana Mendes
    Mattedi, Romulo Loss
    Buchpiguel, Carlos Alberto
    CLINICS, 2011, 66 (01) : 27 - 34
  • [25] Confirmatory biopsy of men under active surveillance: extended versus saturation versus multiparametric magnetic resonance imaging/transrectal ultrasound fusion prostate biopsy
    Pepe, Pietro
    Cimino, Sebastiano
    Garufi, Antonio
    Priolo, Giandomenico
    Russo, Giorgio Ivan
    Giardina, Raimondo
    Reale, Giulio
    Pennisi, Michele
    Morgia, Giuseppe
    SCANDINAVIAN JOURNAL OF UROLOGY, 2017, 51 (04) : 260 - 263
  • [26] Magnetic Resonance Imaging-Transrectal Ultrasound Guided Fusion Biopsy to Detect Progression in Patients with Existing Lesions on Active Surveillance for Low and Intermediate Risk Prostate Cancer
    Frye, Thomas P.
    George, Arvin K.
    Kilchevsky, Amichai
    Maruf, Mahir
    Siddiqui, M. Minhaj
    Kongnyuy, Michael
    Muthigi, Akhil
    Han, Hui
    Parnes, Howard L.
    Merino, Maria
    Choyke, Peter L.
    Turkbey, Baris
    Wood, Brad
    Pinto, Peter A.
    JOURNAL OF UROLOGY, 2017, 197 (03) : 640 - 646
  • [27] A comparison of prostate tumor targeting strategies using magnetic resonance imaging-targeted, transrectal ultrasound-guided fusion biopsy
    Martin, Peter R.
    Cool, Derek W.
    Fenster, Aaron
    Ward, Aaron D.
    MEDICAL PHYSICS, 2018, 45 (03) : 1018 - 1028
  • [28] Deep Learning for Real -time, Automatic, and Scanner-adapted Prostate (Zone) Segmentation of Transrectal Ultrasound, for Example, Magnetic Resonance Imaging ?transrectal Ultrasound
    van Sloun, Ruud J. G.
    Wildeboer, Rogier R.
    Mannaerts, Christophe K.
    Postema, Arnoud W.
    Gayet, Maudy
    Beerlage, Harrie P.
    Salomon, Georg
    Wijkstra, Hessel
    Mischi, Massimo
    EUROPEAN UROLOGY FOCUS, 2021, 7 (01): : 78 - 85
  • [29] Magnetic resonance imaging-transrectal ultrasound fusion focal cryotherapy of the prostate: A prospective development study
    Valerio, Massimo
    Shah, Taimur Tariq
    Shah, Paras
    Mccartan, Neil
    Emberton, Mark
    Arya, Manit
    Ahmed, Hashim Uddin
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (04) : 150.e1 - 150.e7
  • [30] Optimal Number of Systematic Biopsy Cores Used in Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Targeted Prostate Biopsy
    Teraoka, Shogo
    Honda, Masashi
    Shimizu, Ryutaro
    Nishikawa, Ryoma
    Kimura, Yusuke
    Yumioka, Tetsuya
    Iwamoto, Hideto
    Morizane, Shuichi
    Hikita, Katsuya
    Takenaka, Atsushi
    YONAGO ACTA MEDICA, 2021, 64 (03) : 260 - 268